Baron-Delage S, Mahraoui L, Cadoret A, Veissiere D, Taillemite J L, Chastre E, Gespach C, Zweibaum A, Capeau J, Brot-Laroche E, Cherqui G
Laboratoire de Biologie Cellulaire, Institut National de la Santé et de la Recherche Médicale Unité 402, Faculté de Médicine Saint-Antoine, Paris, France.
Am J Physiol. 1996 Feb;270(2 Pt 1):G314-23. doi: 10.1152/ajpgi.1996.270.2.G314.
We investigated whether the oncogenic activation of p21ras or pp60c-src, which is frequently observed in colorectal cancers, induced alterations of sugar uptake in human colonic cells. We therefore examined hexose transporter expression and/or activity in Caco-2 cells transfected either with an activated human (Val-12) Ha-ras gene or with the polyoma middle T (PyMT) oncogene, a constitutive activator of pp60c-src tyrosine kinase activity. Experiments were performed at day 20 of culture, when Caco-2 cells express enterocyte-specific GLUT-2, GLUT-5, and SGLT-1 transporters in addition to GLUT-1 and GLUT-3. Along with increased glucose consumption rates, both oncogene-transfected cells exhibited increased levels of GLUT-1 and GLUT-3 mRNAs and/or immunoreactive proteins compared with control vector Caco-2 cells. In contrast, oncogene-transfected cells lost GLUT-2, GLUT-5, and SGLT-1 expression as determined by Northern and/or Western blot analyses and/or specific transport assays. The oncogene-induced repressive effect on these enterocyte-specific hexose transporters extended to brush-border hydrolases and villin but not to tight junctional protein ZO-1. In conclusion, oncogenic p21ras and PyMT/pp60c-src induce severe deregulation of hexose transporter expression in Caco-2 cells, which is manifested by 1) increased GLUT-1 and GLUT-3 expression and 2) repression of GLUT-2, GLUT-5, and SGLT-1, which parallels repression of some markers of the enterocyte-like differentiated phenotype of Caco-2 cells.
我们研究了在结直肠癌中经常观察到的p21ras或pp60c-src的致癌激活是否会诱导人结肠细胞中糖摄取的改变。因此,我们检测了用激活的人(Val-12)Ha-ras基因或多瘤病毒中T(PyMT)癌基因(pp60c-src酪氨酸激酶活性的组成型激活剂)转染的Caco-2细胞中的己糖转运蛋白表达和/或活性。实验在培养第20天进行,此时Caco-2细胞除了表达GLUT-1和GLUT-3外,还表达肠细胞特异性的GLUT-2、GLUT-5和SGLT-1转运蛋白。与对照载体Caco-2细胞相比,随着葡萄糖消耗率的增加,两种癌基因转染的细胞均表现出GLUT-1和GLUT-3 mRNA水平和/或免疫反应性蛋白水平升高。相反,通过Northern和/或Western印迹分析和/或特异性转运测定确定,癌基因转染的细胞失去了GLUT-2、GLUT-5和SGLT-1的表达。癌基因对这些肠细胞特异性己糖转运蛋白的抑制作用扩展到刷状缘水解酶和绒毛蛋白,但不影响紧密连接蛋白ZO-1。总之,致癌性p21ras和PyMT/pp60c-src诱导Caco-2细胞中己糖转运蛋白表达严重失调,表现为:1)GLUT-1和GLUT-3表达增加;2)GLUT-2、GLUT-5和SGLT-1受抑制,这与Caco-2细胞肠细胞样分化表型的一些标志物的抑制情况相似。